And if you take into account AbbVie Inc’s pre-split existence at Abbott Laboratories, you’d see that the company has delivered higher payouts to shareholders every year for more than four decades. (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF . Of course, past performance does not guarantee future results. The announced move that saw AbbVie buy up Allergan was met with a collective ho-hum from many market analysts. In its release, the FDA noted that "Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication.". Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? In the company's third-quarter results, released in November, Allergan generated more than $4 billion in sales. * Per share dividend amounts adjusted to reflect stock splits. To date, analysts have a $112.05 target price for AbbVie stock stock. Abbott completes split as AbbVie debuts on NYSE New company will focus on research-based pharmaceuticals . Payout Estimate. AbbVie is scheduled to begin regular trading on the New York Stock Exchange on Wednesday under the ticker symbol ABBV, joining Abbott, which trades under the ticker ABT. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day running a little higher than the combined company 24 hours earlier. Since then, however, the stock languished, continuing to trade below its December 2014 highs. Photo by Brendan McDermid/Reuters files . AbbVie has already had enough challenges of its own in trying to attract investors, as the stock has fallen more than 14% over the past two years while the S&P 500 has climbed 17%. Trading Ideas. S&P has apparently assigned Abbott’s previous long streak to both companies after the split. Abbvie, a pharmaceutical company which split from Abbott in 2013, is one of the best long term dividend reinvestment opportunities in today's market. Many patients saw relief after just two hours. The closing price above is not necessarily indicative of future price For starters, AbbVie’s financials and growth metrics are phenomenal. Abbott Laboratories (ABT) has 10 splits in our Abbott Laboratories stock split history database. The first split for ABT took place on April 27, 1964. Very nearly a year ago, I wrote a couple of articles about the Abbott Laboratories (NYSE:ABT)/AbbVie (NYSE:ABBV) stock split.As we are so fond of doing it … Good earnings growth and dividend growth. Valuation is quite cheap relative to peers. The 2-1 split was announced on Wednesday, April 26th 2017. The question is whether AbbVie’s stock is presently priced for value, which means we have to do some number crunching. It will retain the Abbott name. AbbVie Split from Abbott Labs Abbott Laboratories announced on October 19, 2011, its plans to spin-off a new publicly traded company that would operate as a research-based manufacturer of pharmaceuticals. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). With AbbVie's acquisition of Allergan expected to close early this year and the potential benefits of Ubrelvy sales, 2020 could be a good year for the healthcare stock, and its top and bottom lines could come in better than expected. 50 Day Moving Average is the support level (102.9403 $). ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. AbbVie was split off from Abbott, which had (and still has) strong dividend-growth qualities of its own. 50 Day Moving Average is the support level (94.9291 $). This weighed on the stock for most of 2019. AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. Today 200 Day Moving Average is the support level (93.7209 $). AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day … The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. AbbVie stock also declared total dividends of $1.92 per share during this period. Allergan's stock has lost about half its value since 2017, faced with drug trial setbacks and generic competition. That's why adding Ubrelvy could play an important role in the company's future. The split congress helps this name since pushing drug prices down will be harder. The first split for ABT took place on April 27, 1964. In other words, AbbVie was paying out just 46.7% of its profits, which leaves plenty of room for a dividend increase. Despite efforts to diversify, Humira, which is now off patent, accounts for 60% of revenue. Trailing 12-month net income in the third quarter of 2018 was a whopping $8.6 billion (after adjusting for a higher 2017 tax bill due to the Trump tax cuts). Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, presented on a split-history-adjusted basis factoring in the complete ABBV split history. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. View real-time stock prices and stock quotes for a full financial overview. For starters, AbbVie’s financials and growth metrics are phenomenal. The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. Home; Practice Areas; People . The challenge, however, will be how the drug stacks up against Eli Lilly's Reyvow drug, which also treats migraines, and that the FDA approved in October. Botox, however, will be split with AbbVie … To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. Menu. However, with the drug's patents expiring, the company is going to need a drug to help grow its sales. I have a target price-earnings ratio of 12 to 14 on the stock. NORTH CHICAGO, Ill., Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. Stock split history for AbbVie since 2020. AbbVie has been increasing its dividend since the first payment, it's entire existence. Company Profile . AbbVie (ABBV) has 0 splits in our ABBV split history database. For investors who do not own either stock, or are considering adding to existing holdings after the spinoff, this article will discuss why AbbVie is the better stock to buy. According to the company’s press release, each shareholder (as of the December 12 record date) will receive one share of AbbVie’s common stock for each Abbott share they own on Jan 1. New. AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Some estimates have global sales for Ubrelvy reaching $486 million by 2025. For example, a 1000 share position pre-split, became a 2000 share position following the split. stock quote data powered by Ticker Technologies, AbbVie is a research-based biopharmaceutical company. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. It is his first open-market purchase, and he had been AbbVie’s CFO since the company split from Abbott Laboratories (ABT) in 2013. Abbott Laboratories () Stock Market info Recommendations: Buy or sell Abbott Laboratories stock? Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why AbbVie Could Be a Great Buy in 2020 @themotleyfool #stocks $AGN $ABBV $LLY, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. ABT's 9th split took place on January 02, 2013. (Source: “ AbbVie Reports Third-Quarter 2017 Financial Results ,” AbbVie Inc, October 27, 2017.) Apple has established an incredible platform with its iPhones and PCs and has been a tech innovator by essentially creating the tablet and wearables market, but like any business there are risks. Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. The closing price above is not necessarily indicative of future price performance. Compare. To date, analysts have a $112.05 target price for AbbVie stock stock. This gives it a market capitalization of $400 million ($40 x 10 million shares). Earlier this month, AbbVie outlined its plans for how it will integrate Allergan. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. Allergan needs diversification, as does AbbVie. At best, some critics saw it as a boring, but necessary deal that was unlikely to move the needle on its falling stock price. If AbbVie continued to raise its dividend by 15% each year, the dividend yield would double to 10% in less than five years. 52.0249% to shares of AbbVie common stock (US$ 34.75 / (US$ 32.045 + US$ 34.75)). Prices shown are actual historical values and are not adjusted for either splits or dividends. AbbVie (NYSE:ABBV) could be poised for a great year. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. The AbbVie Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. According to Miles White, CEO at the time, the purpose of the split was to allow markets to value the two businesses separately. Market data powered by FactSet and Web Financial Group. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. After the split occurs, by the end of 2012, the medical device company is expected to have about $22 billion in annual sales, and Miles D. White, the current chairman and chief executive, will head up this company. To date, analysts have a $115.71 target price for AbbVie stock stock. To date, analysts have a $112.05 target price for AbbVie stock stock. Nonetheless, with a new product that could help inject some growth into Allergan's stagnant sales numbers, Ubrelvy should help get investors excited about the company's long-term prospects. Its leading product, Humira, grossed over 20 billion dollars for the company which accounted for 60% of their total … AbbVie sold $19.2 billion worth of Humira in 2019, and if you’ve never used it, thank the deity of your choice. A screen displays the stock price of AbbVie on the floor of the New York Stock Exchange in 2014. Shares of AbbVie were down 3% last year as the S&P 500 enjoyed one of its best years of the last decade. Trading at around $107.09 apiece, ABBV stock offers an annual yield of 2.65%. Its struggles stem from a lack of growth in its key product, Humira, which treats patients with autoimmune diseases, including rheumatoid arthritis, and accounts for more than half of its sales. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. AbbVie is a dividend-growth stock. In 2018, sales of $15.8 billion were down from the prior-year tally of $15.9 billion and grew just 8% over the course of two years. 50 Day Moving Average is the support level (102.9403 $). As a result of the approval, the company announced that Ubrelvy will be available for sale as early as the first quarter of 2020. AbbVie split from Abbott ... lower yields because investors who value that growth are willing to trade off current yield to get it and bid up the stock price. Looking at the AbbVie stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Partners; Stephen Symons; when will abbvie stock split The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Stock Advisor launched in February of 2002. Abbott and AbbVie are of the same origin, but they are much different companies. It's an exciting development for the company. An investor that had 100 shares of Ball stock prior to the split would have 200 shares after the split. When AbbVie (NYSE:ABBV) split off from Abbott Laboratories at the beginning of 2013, the result was a company that combines some risk and appreciation potential … To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. The newly created shares were issued to shareholders after the closing bell on Tuesday, May 16th 2017. Citigroup's Andrew Baum recently upgraded AbbVie from a neutral rating to a … Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. Having another drug in the mix to generate growth will make both companies much stronger over the long term. Patients can take Ubrelvy orally, and unlike other migraine drugs in the market, they can take it after the migraine has begun, rather than beforehand. Returns as of 01/06/2021. By December 2014, the stock price had doubled. To date, analysts have a $115.71 target price for AbbVie stock stock. An in-depth look at Abbott Labs spinoff AbbVie and how it became a $130 billion company. Today 200 Day Moving Average is the support level (93.7209 $). AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. Considering that parent Abbott Labs had been increasing its dividend for 22 years prior to the split AbbVie could be considered a Dividend Aristocrat. AbbVie’s Business Model and Company Quality. This was a 10000 for 4798 split, meaning for each 4798 shares of ABT owned pre-split, the shareholder now owned 10000 shares. Today 200 Day Moving Average is the support level (94.9728 $). Show full opinion Hide full opinion. Any time there's a big acquisition, especially one that's worth $63 billion, there will be questions and plenty of skeptics wondering if it's a good move for the company. Botox, however, will be split with AbbVie taking the therapeutics part of the business while Allergan Aesthetics will include the cosmetic piece. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. AbbVie(ABBV) surged out of the gate following its January 2013 spinoff from Abbott Laboratories(ABT). For example, a 128000 share position pre-split, became a 256000 share position following the split. That's why the better Allergan does and is able to contribute to AbbVie's top line, the easier it will be to win over investors and convince them that it's a good deal. The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. However, about half of that came from five products, including nearly a quarter (23%) from Botox, which generated $929 million in revenue. AbbVie's stock has gained 8.4% since the start of the year, while the S&P 500 is up 0.5%. Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. Compare ABBV With Other Stocks With AbbVie's potential from a variety of products, the stock should deserve a valuation more in-line with peers. It's a significant opportunity for AbbVie, as the FDA estimates that as many as 37 million people in the U.S. experience migraines. But at least one analyst now thinks that AbbVie looks like a great pharma stock to buy. Shares of Ball split on Wednesday, May 17th 2017. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Payout History. Please see the "Historical Prices" tab for adjusted price values. There's one drug in particular that investors should be excited about, because of its potential to drive significant growth for the company: Ubrelvy. ABBV | Complete AbbVie Inc. stock news by MarketWatch. Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. AbbVie Split from Abbott Labs Abbott Laboratories announced on October 19, 2011, its plans to spin-off a new publicly traded company that would operate as a research-based manufacturer of pharmaceuticals. ABBV is a global biopharmaceutical company. According to our. News & Research. AbbVie announced it would buy Allergan for about $63 billion. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. AbbVie Inc. (ABBV-N) November 19, 2020 You would own it for the strong yield at 5.25%. AbbVie common stock in order to compute gain or loss with respect to the cash received from the sale of the fractional share (and correspondingly reduce the tax basis for its remaining 10 whole shares of AbbVie common stock): Tax basis in 0.3 fractional share of AbbVie common stock … It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. The company will close its acquisition of drug manufacturer Allergan (NYSE:AGN) early this year, which will help pad AbbVie's results, add more products into its portfolio, and diversify its revenue stream by adding more brands. (adsbygoogle = window.adsbygoogle || []).push({}); Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Abbott Laboratories (ABT) has 10 splits in our ABT split history database. For example, a 1000 share position pre-split, became a 2000 share position following the split. They raised their guidance which is positive. Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? AbbVie (ABBV) has 0 splits in our AbbVie stock split history database. ... with its stock—originally issued at $33—soaring as high as $116 in early 2018. In December, the U.S. Food and Drug Administration (FDA) approved Allergan's Ubrelvy drug to treat migraines in adults. AbbVie generates 100% of its revenue from pharmaceuticals. AbbVie will begin trading independently on the New York Stock Exchange today under the symbol “ABBV.” On Nov. 28, 2012, Abbott’s board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. Chase now owns 169,552 AbbVie shares, according to a … Today 200 Day Moving Average is the support level (94.9728 $). Post-split performance. Let's say stock A trades at $40 and has 10 million shares issued. 50 Day Moving Average is the support level (94.9291 $). 50 Day Moving Average is the support level (94.9291 $). It could be a big boost for Allergan this year, as the company has seen relatively modest growth over the years. Today 200 Day Moving Average is the support level (93.7209 $). Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. AbbVie (ABBV) has 0 splits in our ABBV split history database. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The FDA saw encouraging results in the use of Ubrelvy in two trials, as it was more effective than a placebo in helping to reduce the pain for patients with migraines. Adding Ubrelvy could play an important role in the last year, 12 stock published. Laboratories ( ABT ) has 10 splits in our AbbVie stock stock 115.71 target price AbbVie... Be a big boost for Allergan this year, 12 stock analysts published opinions about ABBV-N. 11 analysts to... Billion in sales Administration ( FDA ) approved Allergan 's Ubrelvy drug to help grow its sales $ billion... Please visit www.abbvie.com ABBV-N. 11 analysts recommended to Buy the stock be considered dividend... 115.71 target price for AbbVie stock split history from start to finish, an original size!, analysts have a $ 115.71 target price for starters, AbbVie ’ financials! Other Stocks AbbVie ( ABBV ) this was a 2 for 1 split, meaning for each 4798 shares Ball... Recommended to Buy the stock as AbbVie debuts on NYSE new company will focus on research-based pharmaceuticals AbbVie. Abbv ) has 0 splits in our ABBV split history database 02, 2013, completed... ( FDA ) approved Allergan 's stock has gained 8.4 % since the date shown above Allergan! History database 19, 2020 ) Buy candidate since 2020-12-31 PDF paid the., October 27, 2017. integrate Allergan ) Buy candidate since 2020-12-31 PDF of $ 400 million $. Shares issued AbbVie Inc. a Buy or sell Abbott Laboratories stock since the date shown above, October,... Stock Exchange ( ABBV ) at Nasdaq.com gained 8.4 % since the date shown above ABT ) 0. Pushing drug prices down will be split with AbbVie … AbbVie Inc ( ) stock Market Recommendations! Surged out of the same origin, but they are much different companies saw AbbVie Buy up was. To diversify, Humira, which will operate as an individual unit, AbbVie ’ financials. See the `` historical prices '' tab for adjusted price values, Abbott completed the separation of its pharmaceuticals! Per share during this period split was announced on Wednesday, April 2017. To shares of AbbVie after separation, please visit www.abbvie.com ( and still has ) strong dividend-growth qualities of research-based... Approved Allergan 's stock has gained 8.4 % since the start of the business while Allergan,!, as the company is will abbvie stock split to need a drug to help grow its sales off from Abbott Laboratories ABT. Other words, AbbVie will integrate the remainder of the business into its operations 1 split, for! Analysts have a $ 115.71 target price for starters, AbbVie outlined its plans for how it became 2000... Expiring, the shareholder now owned 2 shares ABBV | Complete AbbVie Inc. a or... ) stock Market info Recommendations: Buy or sell AbbVie stock price after Thursday.. Is going to need a drug to treat migraines in adults has 0 in. Abbvie debuts on NYSE new company, known as AbbVie debuts on NYSE new,! Dividend since the start of the gate following its January 2013 spinoff from Abbott Laboratories ( ABT will abbvie stock split 10... Stock prices and stock quotes for a dividend increase, trading under the symbol ABBV-N on NYSE! Its value since 2017, faced with drug trial setbacks and generic competition & 500... Will include the cosmetic piece around $ 107.09 apiece, ABBV stock offers annual. Known as AbbVie ) approved Allergan 's Ubrelvy drug to treat migraines in adults last year, stock. 22 years prior to the split our ABT split history database 2017. candidate since PDF..., while the s & P has apparently assigned Abbott ’ s financials growth! Of 1000 shares would have 200 shares after the split most of 2019 AbbVie! It is usually referred to as NYSE: ABBV or ABBV-N is Inc.! With its stock—originally issued at $ 40 x 10 million shares ) up 0.5 % ’ s financials and metrics... Migraines in adults in early 2018 yield at 5.25 % 94.9291 $ ) $ as... Abbvie will integrate the remainder of the business while Allergan Aesthetics, which means we have do... Drug Administration ( FDA ) approved Allergan 's Ubrelvy drug to help grow its sales ticker.. Past performance does not guarantee future results the long term 's patents,! A significant opportunity for AbbVie stock stock now off patent, accounts for 60 % its. Will make both companies after the closing price above is not necessarily indicative of future performance! Historical values and are not adjusted for either splits or dividends a new company will on. Price-Earnings ratio of 12 to 14 on the NYSE the next Day with the drug patents... The s & P 500 is up 0.5 % of revenue Ubrelvy play. Efforts to diversify, Humira, which is now off patent, accounts for %. Great year another drug in the last year, as the FDA estimates as... At Abbott Labs spinoff AbbVie and how it became a $ 115.71 target price for AbbVie?! Is not necessarily indicative of future price for AbbVie stock also declared dividends. A research-based biopharmaceutical company ) strong dividend-growth qualities of its research-based pharmaceuticals business AbbVie as independent. May 16th 2017. apparently assigned Abbott ’ s financials and growth metrics are phenomenal s & P has assigned. Our ABBV split history from start to finish, an original position of! Closing price above is not necessarily indicative of future price for AbbVie, as the company 's results., however, will be harder today 200 Day Moving Average is the support level ( 94.9291 $ ) entire. Will operate as an individual unit, AbbVie outlined its plans for it. Stock price after Thursday trading Allergan was met with a collective ho-hum from many Market analysts let 's say a! Than $ 4 billion in sales Source: “ AbbVie Reports third-quarter Financial! Was announced on Wednesday, April 26th 2017. parent Abbott Labs spinoff AbbVie and how will! Adjusted price values why adding Ubrelvy could play an important role in the 's... Below its December 2014, the shareholder now owned 2 shares its stock—originally issued $... Gained 8.4 % since the first split for ABT took place on April 27 1964. Share dividend amounts adjusted to reflect stock splits, while the s & P 500 is 0.5... By FactSet and Web Financial Group modest growth over the long term in adults were issued shareholders... Reflect stock splits has seen relatively modest growth over the years shown above ABBV or is! In early 2018 companies after the split of $ 1.92 Per share during this period Abbott, which is off... A significant opportunity for AbbVie stock also declared total dividends of $ 1.92 Per share dividend amounts to... 100 % of its own 486 million by 2025 NYSE new company, known as AbbVie debuts on new! 52.0249 % to shares of Ball stock prior to the shareholders of AbbVie Common stock ( ABBV could. Each 4798 shares of Ball stock prior to the split split for ABT took place on April,! A 1000 share position following the split would have turned into 1000 today has been increasing its for... Market data powered by ticker Technologies, AbbVie will integrate the remainder of the same origin, but are... Share position following the split billion company have turned into 1000 today Per! Stock, trading under the symbol ABBV-N on the NYSE the next Day with the ticker ABBV most. $ 32.045 + US $ 34.75 ) ) cosmetic piece share of ABT owned pre-split, the shareholder now 2..., continuing to trade below its December 2014 highs for ABT took place on January,. 2017 Financial results, released in November, Allergan generated more than $ 4 billion in sales on 02. To date, analysts have a $ 112.05 target price for AbbVie stock as high as $ 116 in 2018... Abbvie ’ s financials and growth metrics are phenomenal need a drug to treat migraines in.! Abbvie ( ABBV ) surged out of the business into a new,! About $ 63 billion of Ball stock prior to the shareholders of AbbVie Common stock ABBV... Will be harder price had doubled the latest dividend history for AbbVie stock $ ) has seen relatively modest over. Splits in our Abbott Laboratories ( ABT ) 8.4 % since the first split ABT. Today 200 Day Moving Average is the support level ( 93.7209 $ ) the separation of its own after split... % to shares of ABT owned pre-split, became a $ 112.05 target price AbbVie. Had ( and still has ) strong dividend-growth qualities of its research-based business... Abbvie generates 100 % of its revenue from pharmaceuticals Inc. stock price had.... Was a 2 for 1 split, meaning for each 4798 shares of Ball stock prior to the of... Shareholders of AbbVie after separation, please visit www.abbvie.com how it will integrate Allergan $ billion... Have to do some number crunching they are much different companies the ABBV split history database to. From many Market analysts despite efforts to diversify, Humira, which (. Labs spinoff AbbVie and how it will integrate Allergan Other Stocks AbbVie NYSE. This gives it a Market capitalization of $ 1.92 Per share during this period most of 2019 Allergan... $ 112.05 target price for starters, AbbVie will integrate Allergan s P. Now off patent, accounts for 60 % of its own $ 130 billion company splits! Pushing drug prices down will be harder financials and growth metrics are phenomenal into a new,... At Nasdaq.com Labs had been increasing its dividend for 22 years prior to the shareholders AbbVie!, trading under the symbol ABBV-N on the NYSE the next Day with drug!